Documents

A list of downloadable documents created during development.

Consultation documents published: - scope consultation

Melanoma (BRAF V600E mutation positive, unresectable, metastatic) - dabrafenib and trametinib: draft scope (rescope)

Melanoma (BRAF V600E mutation positive, unresectable, metastatic) - dabrafenib and trametinib: draft matrix (rescope)

Melanoma (BRAF V600E mutation positive, unresectable, metastatic) - dabrafenib and trametinib: draft scope

Melanoma (BRAF V600E mutation positive, unresectable, metastatic) - dabrafenib and trametinib: draft matrix